Education
About Us
Working with TipRanks
Follow Us
WDB coco Co., Ltd. (JP:7079)
:7079
RESEARCH TOOLSreports
Top Page
WDB coco Co., Ltd.
(7079)
76Outperform
WDB coco Co., Ltd. (7079) vs. S&P 500 (SPY)
Market Cap
¥8.30B
Dividend Yield2.32%
Average Volume (3M)1.41K
Price to Earnings (P/E)8.8
Beta (1Y)0.72
Revenue Growth18.87%
EPS Growth21.76%
CountryJP
Employees504
SectorHealthcare
Sector Strength48
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)105.95
Shares Outstanding2,405,000
10 Day Avg. Volume580
30 Day Avg. Volume1,413
Financial Highlights & Ratios
PEG Ratio-14.62
Price to Book (P/B)2.15
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
WDB coco Co., Ltd. Business Overview & Revenue Model
Company DescriptionWDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyWDB coco Co., Ltd. generates its revenue primarily through the provision of temporary staffing services. The company earns money by placing qualified temporary workers in client organizations within the medical and pharmaceutical sectors. The revenue model involves charging client companies for the staffing services provided, which typically includes a markup on the wages paid to the temporary employees. Additionally, the company may have partnerships with various pharmaceutical and healthcare firms, which contribute to consistent demand for its staffing solutions, thereby sustaining its revenue streams.
WDB coco Co., Ltd. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 5.21B | 4.60B | 4.07B | 3.62B | 2.57B | 2.29B | Gross Profit |
| 2.16B | 1.94B | 1.59B | 1.44B | 903.33M | 871.00M | EBIT |
| 1.41B | 1.27B | 1.09B | 963.36M | 524.70M | 473.00M | EBITDA |
| 1.44B | 1.31B | 1.12B | 978.74M | 538.66M | 482.00M | Net Income Common Stockholders |
| 941.68M | 857.83M | 743.63M | 647.70M | 373.18M | 306.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 3.22B | 2.66B | 2.00B | 1.89B | 1.28B | 1.03B | Total Assets |
| 5.22B | 4.66B | 3.66B | 3.13B | 2.13B | 1.78B | Total Debt |
| 0.00 | 27.12M | 24.32M | 33.52M | 19.97M | 7.51M | Net Debt |
| -3.22B | -2.63B | -1.98B | -1.86B | -1.26B | -1.02B | Total Liabilities |
| 1.18B | 1.10B | 858.14M | 985.59M | 564.02M | 541.09M | Stockholders Equity |
| 4.04B | 3.56B | 2.80B | 2.15B | 1.57B | 1.24B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | 684.97M | 452.26M | 706.12M | 291.89M | 335.00M | Operating Cash Flow |
| 0.00 | 772.20M | 517.49M | 747.90M | 293.93M | 372.00M | Investing Cash Flow |
| 0.00 | -91.82M | -302.97M | -60.48M | -1.92M | -110.00M | Financing Cash Flow |
| 0.00 | -110.94M | -101.21M | -79.11M | -42.87M | 272.00M |
WDB coco Co., Ltd. Technical Analysis
Positive
3440.00
Price Trends
3403.62
Positive
3393.56
Positive
3519.29
Negative
Market Momentum
19.48
Negative
57.61
Neutral
40.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7079, the sentiment is Positive. The current price of 3440 is above the 20-day moving average (MA) of 3347.50, above the 50-day MA of 3403.62, and below the 200-day MA of 3519.29, indicating a neutral trend. The MACD of 19.48 indicates Negative momentum. The RSI at 57.61 is Neutral, neither overbought nor oversold. The STOCH value of 40.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7079.
WDB coco Co., Ltd. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥8.30B | 8.81 | 2.32% | 18.87% | 21.76% | ||
73 Outperform | ¥12.62B | 21.71 | 3.19% | 5.12% | -24.22% | ||
71 Outperform | ¥117.71B | 24.01 | 1.17% | 14.56% | 18.64% | ||
70 Outperform | $21.79B | 10.07 | 16.02% | 0.55% | 7.20% | 87.54% | |
52 Neutral | $5.22B | 3.55 | -44.39% | 2.82% | 15.40% | -0.09% | |
45 Neutral | ¥9.51B | ― | ― | 50.61% | -136.32% |
* Healthcare Sector Average
Performance Comparison
JP:7079
WDB coco Co., Ltd.
3,465.00
-941.93
-21.37%
JP:6036
KeePer Technical Laboratory Co.Ltd.
4,350.00
156.39
3.73%
JP:6087
Abist Co., Ltd.
3,190.00
0.02
<0.01%
JP:6094
FreakOut Holdings, Inc.
539.00
-177.00
-24.72%
JP:6191
AirTrip
973.00
-464.12
-32.30%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.